{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:43:22Z","timestamp":1790153002663,"version":"4.0.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40263-019-00696-2","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T12:03:14Z","timestamp":1580299394000},"page":"171-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacotherapy for Cluster Headache"],"prefix":"10.1007","volume":"34","author":[{"given":"Roemer B.","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty G. G.","family":"Doesborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fronczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"1","key":"696_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"1","key":"696_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1526-4610.2011.02028.x","volume":"52","author":"TD Rozen","year":"2012","unstructured":"Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache. 2012;52(1):99\u2013113.","journal-title":"Headache."},{"issue":"8","key":"696_CR3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1526-4610.2006.00534.x","volume":"46","author":"M Schurks","year":"2006","unstructured":"Schurks M, Kurth T, de Jesus J, Jonjic M, Rosskopf D, Diener HC. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006;46(8):1246\u201354.","journal-title":"Headache."},{"issue":"11","key":"696_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.0000000000003715","volume":"88","author":"N Lund","year":"2017","unstructured":"Lund N, Barloese M, Petersen A, Haddock B, Jensen R. Chronobiology differs between men and women with cluster headache, clinical phenotype does not. Neurology. 2017;88(11):1069\u201376.","journal-title":"Neurology."},{"issue":"3","key":"696_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/WNL.58.3.354","volume":"58","author":"A Bahra","year":"2002","unstructured":"Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002;58(3):354\u201361.","journal-title":"Neurology."},{"issue":"9","key":"696_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache S","year":"2013","unstructured":"Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629\u2013808.","journal-title":"Cephalalgia"},{"issue":"Suppl 6","key":"696_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/03331024870070S623","volume":"7","author":"L Kudrow","year":"1987","unstructured":"Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia. 1987;7(Suppl 6):76\u20138.","journal-title":"Cephalalgia."},{"issue":"12","key":"696_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1177\/0333102416673206","volume":"37","author":"D Fontaine","year":"2017","unstructured":"Fontaine D, Blond S, Lucas C, Regis J, Donnet A, Derrey S, et al. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: results of an observational prospective study. Cephalalgia. 2017;37(12):1173\u20139.","journal-title":"Cephalalgia."},{"issue":"2","key":"696_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/ene.13215","volume":"24","author":"S Miller","year":"2017","unstructured":"Miller S, Watkins L, Matharu M. Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients. Eur J Neurol. 2017;24(2):381\u201390.","journal-title":"Eur J Neurol."},{"issue":"8","key":"696_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0333102419856607","volume":"39","author":"IF De Coo","year":"2019","unstructured":"De Coo IF, Marin JC, Silberstein SD, Friedman DI, Gaul C, McClure CK, et al. Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a meta-analysis. Cephalalgia. 2019;39(8):967\u201377.","journal-title":"Cephalalgia."},{"key":"696_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/JPR.S129641","volume":"11","author":"D Fontaine","year":"2018","unstructured":"Fontaine D, Santucci S, Lanteri-Minet M. Managing cluster headache with sphenopalatine ganglion stimulation: a review. J Pain Res. 2018;11:375\u201381.","journal-title":"J Pain Res."},{"issue":"6","key":"696_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11916-017-0626-8","volume":"21","author":"J Mojica","year":"2017","unstructured":"Mojica J, Mo B, Ng A. Sphenopalatine Ganglion block in the management of chronic headaches. Curr Pain Headache Rep. 2017;21(6):27.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"696_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018;17(1):75\u201383.","journal-title":"Lancet Neurol."},{"issue":"Pt 5","key":"696_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/brain\/awf118","volume":"125","author":"MS Matharu","year":"2002","unstructured":"Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002;125(Pt 5):976\u201384.","journal-title":"Brain."},{"issue":"2","key":"696_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","volume":"19","author":"A May","year":"1999","unstructured":"May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19(2):115\u201327.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"7","key":"696_CR16","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1212\/WNL.52.7.1522","volume":"52","author":"PJ Goadsby","year":"1999","unstructured":"Goadsby PJ, May A. PET demonstration of hypothalamic activation in cluster headache. Neurology. 1999;52(7):1522.","journal-title":"Neurology."},{"issue":"9124","key":"696_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(98)02470-2","volume":"352","author":"A May","year":"1998","unstructured":"May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352(9124):275\u20138.","journal-title":"Lancet."},{"issue":"1","key":"696_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11916-001-0011-4","volume":"5","author":"A May","year":"2001","unstructured":"May A, Goadsby PJ. Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep. 2001;5(1):60\u20136.","journal-title":"Curr Pain Headache Rep."},{"issue":"3","key":"696_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1212\/WNL.62.3.516","volume":"62","author":"T Sprenger","year":"2004","unstructured":"Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology. 2004;62(3):516\u20137.","journal-title":"Neurology."},{"issue":"1","key":"696_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/2193-1801-3-64","volume":"3","author":"B Edvardsson","year":"2014","unstructured":"Edvardsson B. Symptomatic cluster headache: a review of 63 cases. Springerplus. 2014;3(1):64.","journal-title":"Springerplus"},{"issue":"6","key":"696_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.pain.2013.02.005","volume":"154","author":"FC Yang","year":"2013","unstructured":"Yang FC, Chou KH, Fuh JL, Huang CC, Lirng JF, Lin YY, et al. Altered gray matter volume in the frontal pain modulation network in patients with cluster headache. Pain. 2013;154(6):801\u20137.","journal-title":"Pain."},{"issue":"13","key":"696_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1177\/0333102414527649","volume":"34","author":"KH Chou","year":"2014","unstructured":"Chou KH, Yang FC, Fuh JL, Huang CC, Lirng JF, Lin YY, et al. Altered white matter microstructural connectivity in cluster headaches: a longitudinal diffusion tensor imaging study. Cephalalgia. 2014;34(13):1040\u201352.","journal-title":"Cephalalgia."},{"issue":"5","key":"696_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1177\/0333102417716932","volume":"38","author":"FC Yang","year":"2018","unstructured":"Yang FC, Chou KH, Kuo CY, Lin YY, Lin CP, Wang SJ. The pathophysiology of episodic cluster headache: Insights from recent neuroimaging research. Cephalalgia. 2018;38(5):970\u201383.","journal-title":"Cephalalgia."},{"issue":"2","key":"696_CR24","doi-asserted-by":"publisher","first-page":"e57896","DOI":"10.1371\/journal.pone.0057896","volume":"8","author":"E Qiu","year":"2013","unstructured":"Qiu E, Wang Y, Ma L, Tian L, Liu R, Dong Z, et al. Abnormal brain functional connectivity of the hypothalamus in cluster headaches. PLoS One. 2013;8(2):e57896.","journal-title":"PLoS One."},{"key":"696_CR25","first-page":"333102418761048","volume":"8","author":"S Ferraro","year":"2018","unstructured":"Ferraro S, Nigri A, Bruzzone MG, Brivio L, Proietti Cecchini A, Verri M, et al. Defective functional connectivity between posterior hypothalamus and regions of the diencephalic-mesencephalic junction in chronic cluster headache. Cephalalgia. 2018;8:333102418761048.","journal-title":"Cephalalgia."},{"issue":"11","key":"696_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0333102410365164","volume":"30","author":"MA Rocca","year":"2010","unstructured":"Rocca MA, Valsasina P, Absinta M, Colombo B, Barcella V, Falini A, et al. Central nervous system dysregulation extends beyond the pain-matrix network in cluster headache. Cephalalgia. 2010;30(11):1383\u201391.","journal-title":"Cephalalgia."},{"issue":"4","key":"696_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jnnp-2014-308122","volume":"86","author":"FC Yang","year":"2015","unstructured":"Yang FC, Chou KH, Fuh JL, Lee PL, Lirng JF, Lin YY, et al. Altered hypothalamic functional connectivity in cluster headache: a longitudinal resting-state functional MRI study. J Neurol Neurosurg Psychiatry. 2015;86(4):437\u201345.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"696_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJM199108013250505","volume":"325","author":"The Sumatriptan Cluster Headache Study Group","year":"1991","unstructured":"The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991;325(5):322\u20136.","journal-title":"N Engl J Med."},{"issue":"1","key":"696_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0404.1993.tb04189.x","volume":"88","author":"K Ekbom","year":"1993","unstructured":"Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D, The Sumatriptan Cluster Headache Study Group. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand. 1993;88(1):63\u20139.","journal-title":"Acta Neurol Scand."},{"issue":"8","key":"696_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1526-4610.2005.05189.x","volume":"45","author":"N Gregor","year":"2005","unstructured":"Gregor N, Schlesiger C, Akova-Ozturk E, Kraemer C, Husstedt IW, Evers S. Treatment of cluster headache attacks with less than 6\u00a0mg subcutaneous sumatriptan. Headache. 2005;45(8):1069\u201372.","journal-title":"Headache."},{"issue":"Suppl 1","key":"696_CR31","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1526-4610.2004.04105.x","volume":"44","author":"DW Dodick","year":"2004","unstructured":"Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache. 2004;44(Suppl 1):S20\u201330.","journal-title":"Headache."},{"issue":"4","key":"696_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1046\/j.1468-2982.1992.1204254.x","volume":"12","author":"K Ekbom","year":"1992","unstructured":"Ekbom K, Waldenlind E, Cole J, Pilgrim A, Kirkham A. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia. 1992;12(4):254\u20136.","journal-title":"Cephalalgia."},{"issue":"10","key":"696_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1526-4610.2011.02017.x","volume":"51","author":"U Kallweit","year":"2011","unstructured":"Kallweit U, Sandor PS. Sumatriptan in excessive doses over 15\u00a0years in a patient with chronic cluster headache. Headache. 2011;51(10):1546\u20138.","journal-title":"Headache"},{"issue":"2","key":"696_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1212\/WNL.0000000000002117","volume":"86","author":"M Leone","year":"2016","unstructured":"Leone M, Proietti Cecchini A. Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache. Neurology. 2016;86(2):194\u20135.","journal-title":"Neurology."},{"issue":"4","key":"696_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1212\/01.WNL.0000046589.45855.30","volume":"60","author":"JA van Vliet","year":"2003","unstructured":"van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630\u20133.","journal-title":"Neurology."},{"issue":"7","key":"696_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1468-2982.1998.1807487.x","volume":"18","author":"JE Hardebo","year":"1998","unstructured":"Hardebo JE, Dahlof C. Sumatriptan nasal spray (20\u00a0mg\/dose) in the acute treatment of cluster headache. Cephalalgia. 1998;18(7):487\u20139.","journal-title":"Cephalalgia."},{"issue":"11","key":"696_CR37","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archneur.63.11.nct60002","volume":"63","author":"E Cittadini","year":"2006","unstructured":"Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006;63(11):1537\u201342.","journal-title":"Arch Neurol."},{"issue":"9","key":"696_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/01.wnl.0000267886.85210.37","volume":"69","author":"AM Rapoport","year":"2007","unstructured":"Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology. 2007;69(9):821\u20136.","journal-title":"Neurology."},{"issue":"8","key":"696_CR39","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1526-4610.2009.01501.x","volume":"49","author":"S Akerman","year":"2009","unstructured":"Akerman S, Holland PR, Lasalandra MP, Goadsby PJ. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache J Head Pain. 2009;49(8):1131\u201343.","journal-title":"Headache J Head Pain"},{"issue":"10","key":"696_CR40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1526-4610.2006.00447.x","volume":"46","author":"S Schuh-Hofer","year":"2006","unstructured":"Schuh-Hofer S, Siekmann W, Offenhauser N, Reuter U, Arnold G. Effect of hyperoxia on neurogenic plasma protein extravasation in the rat dura mater. Headache. 2006;46(10):1545\u201351.","journal-title":"Headache"},{"issue":"1","key":"696_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1526-4610.1981.hed2101001.x","volume":"21","author":"L Kudrow","year":"1981","unstructured":"Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache. 1981;21(1):1\u20134.","journal-title":"Headache."},{"issue":"4","key":"696_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archneur.1985.04060040072015","volume":"42","author":"L Fogan","year":"1985","unstructured":"Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol. 1985;42(4):362\u20133.","journal-title":"Arch Neurol."},{"issue":"22","key":"696_CR43","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1001\/jama.2009.1855","volume":"302","author":"AS Cohen","year":"2009","unstructured":"Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451\u20137.","journal-title":"JAMA."},{"issue":"2","key":"696_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1526-4610.2010.01806.x","volume":"51","author":"TD Rozen","year":"2011","unstructured":"Rozen TD, Fishman RS. Inhaled oxygen and cluster headache sufferers in the United States: use, efficacy and economics: results from the United States Cluster Headache Survey. Headache J Head Face Pain. 2011;51(2):191\u2013200.","journal-title":"Headache J Head Face Pain"},{"issue":"3","key":"696_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/0333102416637817","volume":"37","author":"AS Petersen","year":"2017","unstructured":"Petersen AS, Barloese MC, Lund NL, Jensen RH. Oxygen therapy for cluster headache. A mask comparison trial. A single-blinded, placebo-controlled, crossover study. Cephalalgia. 2017;37(3):214\u201324.","journal-title":"Cephalalgia"},{"issue":"5","key":"696_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1001\/archneur.1985.04060050098017","volume":"42","author":"JP Kittrelle","year":"1985","unstructured":"Kittrelle JP, Grouse DS, Seybold ME. Cluster headache. Local anesthetic abortive agents. Arch Neurol. 1985;42(5):496\u20138.","journal-title":"Arch Neurol."},{"issue":"10","key":"696_CR47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1526-4610.1987.hed2710528.x","volume":"27","author":"JE Hardebo","year":"1987","unstructured":"Hardebo JE, Elner A. Nerves and vessels in the pterygopalatine fossa and symptoms of cluster headache. Headache. 1987;27(10):528\u201332.","journal-title":"Headache."},{"issue":"2","key":"696_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1526-4610.1995.hed3502083.x","volume":"35","author":"L Robbins","year":"1995","unstructured":"Robbins L. Intranasal lidocaine for cluster headache. Headache. 1995;35(2):83\u20134.","journal-title":"Headache."},{"issue":"2","key":"696_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1468-2982.2000.00026.x","volume":"20","author":"A Costa","year":"2000","unstructured":"Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20(2):85\u201391.","journal-title":"Cephalalgia."},{"issue":"2","key":"696_CR50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02909410","volume":"17","author":"D Caleri","year":"1987","unstructured":"Caleri D, Marabini S, Panconesi A, Pietrini U. A pharmacological approach to the analgesizing mechanism of somatostatin in cluster headache. Ric Clin Lab. 1987;17(2):155\u201362.","journal-title":"Ric Clin Lab"},{"key":"696_CR51","first-page":"302","volume-title":"Somatostatin for cluster headache attack. Updating in headache","author":"P Geppetti","year":"1985","unstructured":"Geppetti P, Brocchi A, Caleri D. Somatostatin for cluster headache attack. Updating in headache. Berlin: Springer; 1985. p. 302\u20135."},{"issue":"4","key":"696_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0304-3959(84)90048-4","volume":"18","author":"F Sicuteri","year":"1984","unstructured":"Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain. 1984;18(4):359\u201365.","journal-title":"Pain."},{"issue":"3 Suppl","key":"696_CR53","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1136\/gut.35.3_Suppl.S1","volume":"35","author":"AG Harris","year":"1994","unstructured":"Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;35(3 Suppl):S1\u20134.","journal-title":"Gut."},{"issue":"4","key":"696_CR54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ana.20210","volume":"56","author":"MS Matharu","year":"2004","unstructured":"Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004;56(4):488\u201394.","journal-title":"Ann Neurol."},{"key":"696_CR55","unstructured":"Pharmaceuticals N. Safety and Efficacy Study of SOM230 s.c. in Cluster Headache. 18-02-2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02619617."},{"issue":"1","key":"696_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1468-2982.1996.1601005.x","volume":"16","author":"WJ Meyler","year":"1996","unstructured":"Meyler WJ. Side effects of ergotamine. Cephalalgia. 1996;16(1):5\u201310.","journal-title":"Cephalalgia."},{"issue":"1","key":"696_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1468-2982.1986.0601051.x","volume":"6","author":"PG Andersson","year":"1986","unstructured":"Andersson PG, Jespersen LT. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo. Cephalalgia. 1986;6(1):51\u20134.","journal-title":"Cephalalgia."},{"issue":"3","key":"696_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.bjp.0705456","volume":"140","author":"S Akerman","year":"2003","unstructured":"Akerman S, Williamson DJ, Goadsby PJ. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol. 2003;140(3):558\u201366.","journal-title":"Br J Pharmacol"},{"key":"696_CR59","doi-asserted-by":"crossref","unstructured":"Petersen AS, Barloese MCJ, Snoer A, Soerensen AMS, Jensen RH. Verapamil and cluster headache: still a mystery. A narrative review of efficacy, mechanisms and perspectives. Headache J Head Face Pain. 2019.","DOI":"10.1111\/head.13603"},{"issue":"6","key":"696_CR60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1526-4610.1983.hed2306266.x","volume":"23","author":"JS Meyer","year":"1983","unstructured":"Meyer JS, Hardenberg J. Clinical Effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache J Head Face Pain. 1983;23(6):266\u201377.","journal-title":"Headache J Head Face Pain"},{"issue":"3","key":"696_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1526-4610.1989.hed2903167.x","volume":"29","author":"IJ Gabai","year":"1989","unstructured":"Gabai IJ, Spierings EL. Prophylactic treatment of cluster headache with verapamil. Headache. 1989;29(3):167\u20138.","journal-title":"Headache."},{"issue":"10","key":"696_CR62","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1526-4610.2004.04196.x","volume":"44","author":"JN Blau","year":"2004","unstructured":"Blau JN, Engel HO. Individualizing treatment with verapamil for cluster headache patients. Headache J Head Face Pain. 2004;44(10):1013\u20138.","journal-title":"Headache J Head Face Pain"},{"issue":"7","key":"696_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1526-4610.1990.hed3007411.x","volume":"30","author":"G Bussone","year":"1990","unstructured":"Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411\u20137.","journal-title":"Headache."},{"issue":"6","key":"696_CR64","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1212\/WNL.54.6.1382","volume":"54","author":"M Leone","year":"2000","unstructured":"Leone M, D\u2019Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000;54(6):1382\u20135.","journal-title":"Neurology."},{"issue":"7","key":"696_CR65","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1212\/01.wnl.0000267319.18123.d3","volume":"69","author":"AS Cohen","year":"2007","unstructured":"Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology. 2007;69(7):668\u201375.","journal-title":"Neurology."},{"issue":"2","key":"696_CR66","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10194-010-0289-x","volume":"12","author":"M Lanteri-Minet","year":"2011","unstructured":"Lanteri-Minet M, Silhol F, Piano V, Donnet A. Cardiac safety in cluster headache patients using the very high dose of verapamil (\u2265\u00a0720\u00a0mg\/day). J Headache Pain. 2011;12(2):173\u20136.","journal-title":"J Headache Pain."},{"issue":"14","key":"696_CR67","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/0333102416631968","volume":"36","author":"H Koppen","year":"2016","unstructured":"Koppen H, Stolwijk J, Wilms EB, van Driel V, Ferrari MD, Haan J. Cardiac monitoring of high-dose verapamil in cluster headache: an international Delphi study. Cephalalgia. 2016;36(14):1385\u20138.","journal-title":"Cephalalgia."},{"issue":"6","key":"696_CR68","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1046\/j.1468-2982.1997.1706673.x","volume":"17","author":"T Steiner","year":"1997","unstructured":"Steiner T, Hering R, Couturier E, Davies P, Whitmarsh T. Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia. 1997;17(6):673\u20135.","journal-title":"Cephalalgia."},{"issue":"4","key":"696_CR69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1526-4610.1981.hed2104132.x","volume":"21","author":"K Ekbom","year":"1981","unstructured":"Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache. 1981;21(4):132\u20139.","journal-title":"Headache."},{"issue":"1","key":"696_CR70","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1212\/WNL.53.1.234","volume":"53","author":"SD Wheeler","year":"1999","unstructured":"Wheeler SD, Carrazana EJ. Topiramate-treated cluster headache. Neurology. 1999;53(1):234\u20136.","journal-title":"Neurology."},{"issue":"8","key":"696_CR71","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1046\/j.1526-4610.2002.02183.x","volume":"42","author":"NT Mathew","year":"2002","unstructured":"Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache. 2002;42(8):796\u2013803.","journal-title":"Headache."},{"issue":"7","key":"696_CR72","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1046\/j.1526-4610.2003.03137.x","volume":"43","author":"MJ Lainez","year":"2003","unstructured":"Lainez MJ, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A. Topiramate in the prophylactic treatment of cluster headache. Headache. 2003;43(7):784\u20139.","journal-title":"Headache."},{"issue":"2","key":"696_CR73","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0028-3886.63784","volume":"58","author":"WY Huang","year":"2010","unstructured":"Huang WY, Lo MC, Wang SJ, Tsai JJ, Wu HM. Topiramate in prevention of cluster headache in the Taiwanese. Neurol India. 2010;58(2):284\u20137.","journal-title":"Neurol India"},{"issue":"10","key":"696_CR74","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1046\/j.1468-2982.2003.00665.x","volume":"23","author":"M Leone","year":"2003","unstructured":"Leone M, Dodick D, Rigamonti A, D\u2019Amico D, Grazzi L, Mea E, et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia. 2003;23(10):1001\u20132.","journal-title":"Cephalalgia."},{"issue":"7","key":"696_CR75","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1468-2982.1996.1607494.x","volume":"16","author":"M Leone","year":"1996","unstructured":"Leone M, D\u2019Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996;16(7):494\u20136.","journal-title":"Cephalalgia."},{"issue":"10","key":"696_CR76","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1046\/j.1468-2982.2001.00307.x","volume":"21","author":"MF Peres","year":"2001","unstructured":"Peres MF, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia. 2001;21(10):993\u20135.","journal-title":"Cephalalgia."},{"issue":"8","key":"696_CR77","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1526-4610.2002.02181.x","volume":"42","author":"T Pringsheim","year":"2002","unstructured":"Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aube M. Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache. 2002;42(8):787\u201392.","journal-title":"Headache."},{"issue":"3","key":"696_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1468-2982.1989.903195.x","volume":"9","author":"R Hering","year":"1989","unstructured":"Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia. 1989;9(3):195\u20138.","journal-title":"Cephalalgia."},{"issue":"3","key":"696_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1468-2982.2002.00349.x","volume":"22","author":"M El Amrani","year":"2002","unstructured":"El Amrani M, Massiou H, Bousser MG. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia. 2002;22(3):205\u20138.","journal-title":"Cephalalgia."},{"issue":"5","key":"696_CR80","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1468-2982.1993.1305309.x","volume":"13","author":"M Leone","year":"1993","unstructured":"Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia. 1993;13(5):309\u201317.","journal-title":"Cephalalgia."},{"issue":"4","key":"696_CR81","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/head.12491","volume":"55","author":"TD Rozen","year":"2015","unstructured":"Rozen TD. Clomiphene citrate as a preventive treatment for intractable chronic cluster headache: a second reported case with long-term follow-up. Headache. 2015;55(4):571\u20134.","journal-title":"Headache."},{"issue":"2","key":"696_CR82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1526-4610.2007.00995.x","volume":"48","author":"T Rozen","year":"2008","unstructured":"Rozen T. Clomiphene citrate for treatment refractory chronic cluster headache. Headache. 2008;48(2):286\u201390.","journal-title":"Headache."},{"issue":"9","key":"696_CR83","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1590\/0004-282x20170119","volume":"75","author":"ME Nobre","year":"2017","unstructured":"Nobre ME, Peres MFP, Moreira PFF, Leal AJ. Clomiphene treatment may be effective in refractory episodic and chronic cluster headache. Arq Neuropsiquiatr. 2017;75(9):620\u20134.","journal-title":"Arq Neuropsiquiatr."},{"issue":"11","key":"696_CR84","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0333102416660551","volume":"37","author":"EA MacGregor","year":"2017","unstructured":"MacGregor EA, Evers S, International Headache S. The role of methysergide in migraine and cluster headache treatment worldwide\u2014a survey in members of the International Headache Society. Cephalalgia. 2017;37(11):1106\u20138.","journal-title":"Cephalalgia."},{"issue":"4","key":"696_CR85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0333102414539057","volume":"35","author":"L Neeb","year":"2015","unstructured":"Neeb L, Anders L, Euskirchen P, Hoffmann J, Israel H, Reuter U. Corticosteroids alter CGRP and melatonin release in cluster headache episodes. Cephalalgia. 2015;35(4):317\u201326.","journal-title":"Cephalalgia."},{"issue":"4","key":"696_CR86","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1468-2982.2004.00855.x","volume":"25","author":"F Antonaci","year":"2005","unstructured":"Antonaci F, Costa A, Candeloro E, Sjaastad O, Nappi G. Single high-dose steroid treatment in episodic cluster headache. Cephalalgia. 2005;25(4):290\u20135.","journal-title":"Cephalalgia."},{"issue":"3","key":"696_CR87","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jnnp.64.3.418","volume":"64","author":"C Cianchetti","year":"1998","unstructured":"Cianchetti C, Zuddas A, Marchei F. High dose intravenous methylprednisolone in cluster headache. J Neurol Neurosurg Psychiatry. 1998;64(3):418.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"Suppl 1","key":"696_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10072-018-3383-5","volume":"39","author":"G D\u2019Arrigo","year":"2018","unstructured":"D\u2019Arrigo G, Di Fiore P, Galli A, Frediani F. High dosage of methylprednisolone in cluster headache. Neurol Sci. 2018;39(Suppl 1):157\u20138.","journal-title":"Neurol Sci."},{"issue":"5","key":"696_CR89","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s10072-003-0182-3","volume":"24","author":"P Mir","year":"2003","unstructured":"Mir P, Alberca R, Navarro A, Montes E, Martinez E, Franco E, et al. Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone. Neurol Sci. 2003;24(5):318\u201321.","journal-title":"Neurol Sci."},{"issue":"1","key":"696_CR90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/2193-1801-2-156","volume":"2","author":"S Kawada","year":"2013","unstructured":"Kawada S, Kashihara K, Imamura T, Ohno M. High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache. Springerplus. 2013;2(1):156.","journal-title":"Springerplus."},{"issue":"1\u20132","key":"696_CR91","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pain.2006.01.016","volume":"122","author":"SK Afridi","year":"2006","unstructured":"Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes\u2013prolonged effects from a single injection. Pain. 2006;122(1\u20132):126\u20139.","journal-title":"Pain."},{"issue":"8","key":"696_CR92","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0333102412443335","volume":"32","author":"AR Gantenbein","year":"2012","unstructured":"Gantenbein AR, Lutz NJ, Riederer F, Sandor PS. Efficacy and safety of 121 injections of the greater occipital nerve in episodic and chronic cluster headache. Cephalalgia. 2012;32(8):630\u20134.","journal-title":"Cephalalgia."},{"issue":"2","key":"696_CR93","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/ene.12321","volume":"21","author":"G Lambru","year":"2014","unstructured":"Lambru G, Abu Bakar N, Stahlhut L, McCulloch S, Miller S, Shanahan P, et al. Greater occipital nerve blocks in chronic cluster headache: a prospective open-label study. Eur J Neurol. 2014;21(2):338\u201343.","journal-title":"Eur J Neurol."},{"issue":"1\u20132","key":"696_CR94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pain.2005.07.015","volume":"118","author":"A Ambrosini","year":"2005","unstructured":"Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118(1\u20132):92\u20136.","journal-title":"Pain."},{"issue":"4","key":"696_CR95","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11916-013-0325-z","volume":"17","author":"E Leroux","year":"2013","unstructured":"Leroux E, Ducros A. Occipital injections for trigemino-autonomic cephalalgias: evidence and uncertainties. Curr Pain Headache Rep. 2013;17(4):325.","journal-title":"Curr Pain Headache Rep."},{"issue":"10","key":"696_CR96","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(11)70186-7","volume":"10","author":"E Leroux","year":"2011","unstructured":"Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2011;10(10):891\u20137.","journal-title":"Lancet Neurol."},{"issue":"7","key":"696_CR97","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1468-2982.2002.00410.x","volume":"22","author":"MF Peres","year":"2002","unstructured":"Peres MF, Stiles MA, Siow HC, Rozen TD, Young WB, Silberstein SD. Greater occipital nerve blockade for cluster headache. Cephalalgia. 2002;22(7):520\u20132.","journal-title":"Cephalalgia."},{"key":"696_CR98","doi-asserted-by":"crossref","unstructured":"M. Anthony. Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In: Clifford Rose F, editor. Clinical and research advances 5th International Symposium, London, September 1984. Basel, Karger; 1985. pp. 169\u201373.","DOI":"10.1159\/000411505"},{"issue":"9","key":"696_CR99","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0333102416654886","volume":"37","author":"C Gaul","year":"2017","unstructured":"Gaul C, Roguski J, Dresler T, Abbas H, Totzeck A, Gorlinger K, et al. Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: a prospective observational study. Cephalalgia. 2017;37(9):873\u201380.","journal-title":"Cephalalgia."},{"key":"696_CR100","unstructured":"Brandt RB. GON-injection for a Sooner and Better Treatment of Cluster Headache (CHIANTI). 2019 10-10-2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04014634?term=CHIANTI&rank=1."},{"issue":"12","key":"696_CR101","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1468-2982.2004.00734.x","volume":"24","author":"HC Siow","year":"2004","unstructured":"Siow HC, Pozo-Rosich P, Silberstein SD. Frovatriptan for the treatment of cluster headaches. Cephalalgia. 2004;24(12):1045\u20138.","journal-title":"Cephalalgia."},{"issue":"1","key":"696_CR102","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1526-4610.2010.01772.x","volume":"51","author":"L Pageler","year":"2011","unstructured":"Pageler L, Katsarava Z, Lampl C, Straube A, Evers S, Diener HC, et al. Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache. 2011;51(1):129\u201334.","journal-title":"Headache."},{"issue":"6","key":"696_CR103","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1526-4610.1990.hed3006334.x","volume":"30","author":"SD Silberstein","year":"1990","unstructured":"Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 1990;30(6):334\u20139.","journal-title":"Headache."},{"issue":"3","key":"696_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1526-4610.2004.04055.x","volume":"44","author":"E Magnoux","year":"2004","unstructured":"Magnoux E, Zlotnik G. Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache. 2004;44(3):249\u201355.","journal-title":"Headache."},{"issue":"8","key":"696_CR105","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1526-4610.1991.hed3108525.x","volume":"31","author":"PJ Mather","year":"1991","unstructured":"Mather PJ, Silberstein SD, Schulman EA, Hopkins MM. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache. 1991;31(8):525\u201332.","journal-title":"Headache."},{"issue":"Suppl 1","key":"696_CR106","first-page":"S26","volume":"37","author":"NT Mathew","year":"1997","unstructured":"Mathew NT. Dosing and administration of ergotamine tartrate and dihydroergotamine. Headache. 1997;37(Suppl 1):S26\u201332.","journal-title":"Headache."},{"issue":"20","key":"696_CR107","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","volume":"77","author":"AJ Nagy","year":"2011","unstructured":"Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011;77(20):1827\u201332.","journal-title":"Neurology."},{"issue":"Pt 3","key":"696_CR108","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","volume":"117","author":"PJ Goadsby","year":"1994","unstructured":"Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117(Pt 3):427\u201334.","journal-title":"Brain"},{"issue":"2","key":"696_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 1995;60(2):119\u201323.","journal-title":"Pain."},{"issue":"Pt 2","key":"696_CR110","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/brain\/120.2.283","volume":"120","author":"M Fanciullacci","year":"1997","unstructured":"Fanciullacci M, Alessandri M, Sicuteri R, Marabini S. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain. 1997;120(Pt 2):283\u20138.","journal-title":"Brain."},{"issue":"10","key":"696_CR111","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2018.1675","volume":"75","author":"ALH Vollesen","year":"2018","unstructured":"Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, et al. Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial. JAMA Neurol. 2018;75(10):1187\u201397.","journal-title":"JAMA Neurol."},{"issue":"2","key":"696_CR112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","volume":"381","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, et al. Trial of galcanezumab in prevention of episodic cluster headache. N Engl J Med. 2019;381(2):132\u201341.","journal-title":"N Engl J Med."},{"key":"696_CR113","unstructured":"Company ELa. FDA Approves Emgality\u00ae (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks. 04-06-2019. https:\/\/www.prnewswire.com\/news-releases\/fda-approves-emgality-galcanezumab-gnlm-as-the-first-and-only-medication-for-the-treatment-of-episodic-cluster-headache-that-reduces-the-frequency-of-attacks-300862172.html."},{"key":"696_CR114","unstructured":"Ltd. TPI. Teva Announces Update on Fremanezumab Clinical Development for use in Episodic Cluster Headache. 2019 23-04-2019. https:\/\/www.businesswire.com\/news\/home\/20190423005570\/en\/."},{"key":"696_CR115","unstructured":"Ltd. TPI. Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache. 2018 15-06-2018. https:\/\/tevapharm.com\/news\/teva_provides_update_on_clinical_trial_of_fremanezumab_for_use_in_chronic_cluster_headache_06_18.aspx."},{"key":"696_CR116","unstructured":"Company ELa. Lilly\u2019s Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache. 2018 15-05-2018. https:\/\/www.prnewswire.com\/news-releases\/lillys-galcanezumab-meets-primary-endpoint-in-phase-3-study-evaluating-galcanezumab-for-the-prevention-of-episodic-cluster-headache-300648022.html."},{"issue":"9","key":"696_CR117","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/head.12068","volume":"53","author":"H Hidalgo","year":"2013","unstructured":"Hidalgo H, Uhl V, Gantenbein AR, Sandor PS, Kallweit U. Efficiency of sodium oxybate in episodic cluster headache. Headache. 2013;53(9):1490\u20131.","journal-title":"Headache."},{"issue":"1","key":"696_CR118","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1212\/WNL.0b013e31822313c6","volume":"77","author":"R Khatami","year":"2011","unstructured":"Khatami R, Tartarotti S, Siccoli MM, Bassetti CL, Sandor PS. Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache. Neurology. 2011;77(1):67\u201370.","journal-title":"Neurology."},{"issue":"5","key":"696_CR119","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11916-014-0413-8","volume":"18","author":"A Govare","year":"2014","unstructured":"Govare A, Leroux E. Licit and illicit drug use in cluster headache. Curr Pain Headache Rep. 2014;18(5):413.","journal-title":"Curr Pain Headache Rep."},{"issue":"14","key":"696_CR120","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/0333102412458190","volume":"32","author":"P Rossi","year":"2012","unstructured":"Rossi P, Allena M, Tassorelli C, Sances G, Di Lorenzo C, Faroni JV, et al. Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia. 2012;32(14):1031\u201340.","journal-title":"Cephalalgia."},{"key":"696_CR121","first-page":"333102418804160","volume":"5","author":"IF de Coo","year":"2018","unstructured":"de Coo IF, Naber WC, Wilbrink LA, Haan J, Ferrari MD, Fronczek R. Increased use of illicit drugs in a Dutch cluster headache population. Cephalalgia. 2018;5:333102418804160.","journal-title":"Cephalalgia."},{"issue":"12","key":"696_CR122","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","volume":"66","author":"RA Sewell","year":"2006","unstructured":"Sewell RA, Halpern JH, Pope HG Jr. Response of cluster headache to psilocybin and LSD. Neurology. 2006;66(12):1920\u20132.","journal-title":"Neurology."},{"key":"696_CR123","unstructured":"Schindler E. July 17, 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02981173."},{"key":"696_CR124","unstructured":"Petersen AS. Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache. 2019 27-11-2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04179266."},{"key":"696_CR125","unstructured":"Corporation ZP. Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches. 21-11-2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04066023."},{"issue":"15","key":"696_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1129-2377-15-79","volume":"27","author":"DD Mitsikostas","year":"2014","unstructured":"Mitsikostas DD, Edvinsson L, Jensen RH, Katsarava Z, Lampl C, Negro A, et al. Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain. 2014;27(15):79.","journal-title":"J Headache Pain."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-019-00696-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T20:53:16Z","timestamp":1722372796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-019-00696-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1007\/s40263-019-00696-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"29 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"MDF has received consultancy fees from Medtronic, Salvia, Novartis, Amgen, Lilly and TEVA. RF has carried out advisory work for Lilly, TEVA and Allergan and received lecture fees from Novartis. JH has carried out advisory work for Lilly. RBB and PGGD have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript. Open access of this paper is funded by the Leiden University, that provides researchers the opportunity to publish a limited number of papers per year with open access with certain publishers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}